Sensex Latest Revision: Tata Motors is the Newest Entrant, Dr Reddy Exits

  • Stock Market News
Sensex Latest Revision: Tata Motors is the Newest Entrant, Dr Reddy Exits
Credit: © Reuters.

By Malvika Gurung -- Starting Monday, Dec 19, 2022, the pharmaceutical giant Dr. Reddy’s Laboratories (NS: REDY ) will no longer be a part of the benchmark equity index Sensex , as it has been replaced by the behemoth Tata Group company Tata Motors (NS: TAMO ).

In the semi-annual rebalance of the 30-scrip headline index scheduled on Dec 16, 2022, Tata Motors has toppled Dr Reddy’s Labs, based upon a weighted methodology of float-adjusted market capitalization. Experts believe that the rejig has been made on the basis of stock performance.

The semi-annual reshuffle is done twice a year in June and December.

As per an report dated Dec 15, 2022, Nuvama Alternative and Quantitative Research estimated an inflow of $124 million in Sensex with the entry of Tata Motors having a weightage of 1.1% and an outflow of $90 million by the exit of Dr Reddy's Labs.

IIFL Alternative Research has pegged an inflow of nearly $150 million and an outflow of about $130 million in the headline index by the periodic rejig.

With the exit of Dr Reddy’s Labs, only one pharmaceutical stock now remains in Sensex, the mega-cap stock Sun Pharmaceuticals (NS: SUN ).

Further, Adani Power (NS: ADAN ) and Indian Hotels (NS: IHTL ) Company will replace Adani Total Gas (NS: ADAG ) and Hindustan Petroleum (NS: HPCL ) in the BSE 100 index as well as the Sensex Next 50 index, BSE had announced.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or


Related Articles